Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Accolade (DE:4NE1)
FRANKFURT:4NE1
Holding DE:4NE1?
Track your performance easily
4NE1 Stock Chart & Stats
Day’s Range€0 - €0
52-Week Range€2.82 - €13.60
Previous Close€3.4
Volume0.00
Average Volume (3M)N/A
Market Cap
€281.18M
Enterprise Value€285.37M
Total Cash (Recent Filing)$234.35M
Total Debt (Recent Filing)$238.81M
Price to Earnings (P/E)―
Beta1.16
Next Earnings
Jan 13, 2025EPS Estimate
-€0.31Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding80,537,080
10 Day Avg. Volume0
30 Day Avg. VolumeN/A
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)0.66
Price to Sales (P/S)0.68
Price to Cash Flow (P/CF)18.00
P/FCF Ratio24.10
Enterprise Value/Market CapN/A
Enterprise Value/Revenue0.65
Enterprise Value/Gross Profit1.49
Enterprise Value/Ebitda-8.77
Forecast
1Y Price Target
€6.76Price Target Upside95.28% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering12
Accolade News
Bulls Say, Bears Say
Bulls Say
Business DevelopmentAccolade's diversified platform, partner ecosystem, and distribution channels offer resilience as customers increasingly focus on managing complex healthcare benefits, ensuring continued business growth.
Financial PerformanceThe company is on track to achieve its first full year of positive adjusted EBITDA and cash flow, highlighting a significant milestone in financial stability.
Market PositionA weaker funding environment for private peers could provide a competitive advantage, enhancing Accolade's market position.
Bears Say
Financial RiskAccolade's net cash balance of ~$20MM is likely too small to avoid a follow-on debt offering as its current convertible is due in April 2026.
Pricing PressureFears of increasing pricing pressures were likely stoked by CalPERS choosing a competitor over Accolade in a competitive RFP process.
Revenue GuidanceInvestors are looking for stability following multiple resets to revenue guidance.
---
Options Prices
Currently, No data available
---
Ownership Overview
9.77% Insiders
15.47% Mutual Funds
23.11% Other Institutional Investors
34.07% Public Companies and
Individual Investors
4NE1 FAQ
What was Accolade’s price range in the past 12 months?
Accolade lowest stock price was €2.82 and its highest was €13.60 in the past 12 months.
What is Accolade’s market cap?
Currently, no data Available
When is Accolade’s upcoming earnings report date?
Accolade’s upcoming earnings report date is Jan 13, 2025 which is in 60 days.
How were Accolade’s earnings last quarter?
Accolade released its earnings results on Oct 08, 2024. The company reported -€0.282 earnings per share for the quarter, beating the consensus estimate of -€0.416 by €0.134.
Is Accolade overvalued?
According to Wall Street analysts Accolade’s price is currently Undervalued.
Does Accolade pay dividends?
Accolade does not currently pay dividends.
What is Accolade’s EPS estimate?
Accolade’s EPS estimate is -€0.31.
How many shares outstanding does Accolade have?
Accolade has 80,537,080 shares outstanding.
What happened to Accolade’s price movement after its last earnings report?
Accolade reported an EPS of -€0.282 in its last earnings report, beating expectations of -€0.416. Following the earnings report the stock price went up 8.284%.
Which hedge fund is a major shareholder of Accolade?
Among the largest hedge funds holding Accolade’s share is ARK Investment Management LLC. It holds Accolade’s shares valued at 20M.
---
Accolade Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
€6.76 (95.28% Upside)
€6.76 (95.28% Upside)
Blogger Sentiment
Bullish
DE:4NE1 Sentiment 100%
Sector Average 73%
Sector Average 73%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-47.45%
12-Months-Change
Fundamentals
Return on Equity
-18.61%
Trailing 12-Months
Asset Growth
-11.50%
Trailing 12-Months
Company Description
Accolade
Accolade Inc offers technology-enabled solutions that help people better understand, navigate, and utilize the healthcare system and their workplace benefits. it generates revenue through providing personalized health guidance solutions to members.
---
4NE1 Company Deck
---
4NE1 Earnings Call
Q2 2024
0:00 / 0:00
---
4NE1 Stock 12 Month Forecast
Average Price Target
€6.76
▲(95.28% Upside)
Technical Analysis
Best Analysts Covering 4NE1
1 Year
1 Year Success Rate
5/19 ratings generated profit
1 Year Average Return
-21.65%
reiterated a buy rating last month
Copying Ryan MacDonald's trades and holding each position for 1 Year would result in 26.32% of your transactions generating a profit, with an average return of -21.65% per trade.
---